alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute on Aging Initial Review Group; Neuroscience of Aging Review Committee, NIA—N.                    

*Date:*                         February 7-8, 2019.                    

*Time:*                         8:00 a.m. to 2:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Marriott Bethesda North Hotel & Conference Center, 5701 Marinelli Road, Rockville, MD 20852.                    

*Contact Person:*                         Greg Bissonette, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute on Aging, 7201 Wisconsin Avenue, Gateway Building, Suite 2W200, Bethesda, MD 20892, 301-402-1622,                         *bissonettegb@mail.nih.gov*.                    

This meeting notice is being published less than 15 days in advance of the meeting due to the partial Government shutdown of December 2018.

(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS)

Dated: January 23, 2019.

Melanie J. Pantoja,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2019-00280 Filed 1-29-19; 8:45 am]

 BILLING CODE 4140-01-P
xml version="1.0" encoding="UTF-8"?


L\_2021018EN.01000101.xml


| | | | |
| --- | --- | --- | --- |
| 20.1.2021 | EN | Official Journal of the European Union | L 18/1 |

---

DECISION No 1/EC/2020

of 10 December 2020

of the Joint Committee set up under the Agreement on Mutual Recognition between the European Community and Japan related to the registration of a conformity assessment body under the Sectoral Annex on Telecommunications Terminal Equipment and Radio Equipment [2021/43]

THE JOINT COMMITTEE,

Having regard to the Agreement on Mutual Recognition between the European Community and Japan and, in particular, Article 8(3)(a) and Article 9(1)(b) thereof,

Whereas the Joint Committee is to take a Decision to register a conformity assessment body or bodies under a Sectoral Annex,

HAS DECIDED AS FOLLOWS:

| | | | | | | | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. | The conformity assessment body indicated below is registered under the Sectoral Annex on Telecommunications Terminal Equipment and Radio Equipment of the Agreement, for the products and conformity assessment procedures as indicated below. This registration concerns an extension of scope of a designated CAB under the Sectoral Annex on Telecommunications Terminal Equipment and Radio Equipment in order to include Telecommunication Business Law, in addition to Radio Law. | | | --- | | Name, acronym and contact details of the Conformity Assessment Body: Name: PHOENIX TESTLAB GmbH Address: Königswinkel 10, D-32825 Blomberg, GERMANY Telephone number: +49 5235 9500 24 Fax number: +49 5235 9500 28 E-mail address: bentje.holger@phoenix-testlab.de URL address: http://www.phoenix-testlab.de Contact person of the designated CAB: Holger Bentje | | | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Scope of registration in terms of products and conformity assessment procedures: | | | | | | | | --- | --- | --- | --- | --- | --- | | | For Telecommunication Business Law | | | | --- | --- | | — | Terminal equipment for the purpose of calls (all equipment) | | | | | --- | --- | | — | Terminal equipment except the preceding item (all equipment) | | | | | | | | --- | --- | --- | --- | | | For Radio Law: | | | | --- | --- | | — | Specified Radio Equipment specified in Article 38-2-2, paragraph (1), items (i), (ii), (iii) of the Radio Law | | | |

| | |
| --- | --- |
| 2. | This Decision replaces any previous registration of the said conformity assessment body as for the applicable laws, regulations and administrative provisions specified in paragraph 1. |

| | |
| --- | --- |
| 3. | This Decision, done in duplicate, shall be signed by the Co-Chairs. The Decision shall be effective from the date of the later of these signatures. |

Tokyo, 6 November 2020

On behalf of Japan

Daisuke NIHEI

Brussels, 10 December 2020

On behalf of the European Union

Lucian CERNAT

---
### §5307. Apportionment of benefits

(a) All or any part of the compensation, pension, or emergency officers' retirement pay payable on account of any veteran may—

(1) if the veteran is being furnished hospital treatment, institutional, or domiciliary care by the United States, or any political subdivision thereof, be apportioned on behalf of the veteran's spouse, children, or dependent parents; and

(2) if the veteran is not living with the veteran's spouse, or if the veteran's children are not in the custody of the veteran, be apportioned as may be prescribed by the Secretary.

(b) Where any of the children of a deceased veteran are not in the custody of the veteran's surviving spouse, the pension, compensation, or dependency and indemnity compensation otherwise payable to the surviving spouse may be apportioned as prescribed by the Secretary.

(c) If a veteran is not living with the veteran's spouse, or if any of the veteran's children are not in the custody of the veteran, any subsistence allowance payable to the veteran under chapter 31 of this title or that portion of the educational assistance allowance payable on account of dependents under chapter 34 of this title may be apportioned as may be prescribed by the Secretary.

(Pub. L. 85–857, Sept. 2, 1958, 72 Stat. 1231, §3107; Pub. L. 92–540, title V, §505, Oct. 24, 1972, 86 Stat. 1099; Pub. L. 98–160, title VII, §703(2), Nov. 21, 1983, 97 Stat. 1010; renumbered §5307, Pub. L. 102–40, title IV, §402(b)(1), May 7, 1991, 105 Stat. 238; Pub. L. 102–83, §4(b)(1), (2)(E), Aug. 6, 1991, 105 Stat. 404, 405.)

#### **Editorial Notes**

#### Amendments

1991—Pub. L. 102–40 renumbered section 3107 of this title as this section.

Subsecs. (a)(2), (b), (c). Pub. L. 102–83 substituted "Secretary" for "Administrator".

1983—Subsec. (a)(1). Pub. L. 98–160, §703(2)(A), substituted "the veteran's spouse" for "his wife".

Subsec. (a)(2). Pub. L. 98–160, §703(2)(A)–(C), substituted "the veteran's spouse" for "his wife", "the veteran's children" for "his children", and "the custody of the veteran" for "his custody".

Subsec. (b). Pub. L. 98–160, §703(2)(D), substituted "surviving spouse" for "widow" in two places.

Subsec. (c). Pub. L. 98–160, §703(2)(A)–(C), (E), substituted "the veteran's spouse" for "his wife", "the veteran's children" for "his children", "the custody of the veteran" for "his custody", and "payable to the veteran" for "payable to him".

1972—Subsec. (c). Pub. L. 92–540 inserted provisions relating to that portion of the educational assistance allowance payable on account of dependents under chapter 34 of this title.

#### **Statutory Notes and Related Subsidiaries**

#### Effective Date of 1972 Amendment

Amendment by Pub. L. 92–540 effective 90 days after Oct. 24, 1972, see section 601(b) of Pub. L. 92–540, set out as a note under section 4101 of this title.
Agency Spotlight

----

December 1998
**Department of Energy (DOE)** - DOE, in cooperation with the Russian Ministry ofAtomicEnergy, has introduced the Nuclear Cities Initiative.  This project focuses on ten closed nuclearcities of the Russian Federation, with the short-term goal of providing civilian employment fordisplaced weapons workers of these cities.  The long-term goal is to assist the Russian Federationto reduce the size of its nuclear weapons complex.  After assessment trips by DOE, the privatesector will be invited to assess business opportunities and job creation in those cities.   For moreinformation, contact Reeshemah Speaks at tel: (202) 586-6568, e-mail:[email protected], or Denise Tramble at tel: (202) 586-1007, e-mail:[email protected].
**International Research & Exchanges Board (IREX)** - IREX seeks host institutions fortheFreedom Support Act Fellowships in Contemporary Issues.  This program brings policymakers,government officials, practitioners, and professionals from the NIS to the United States toconduct research for three months.  The research should be focused on the development of freemarkets and democracy.  The program is funded by the United States Information Agency(USIA).  For more information, visit the IREX website at www.irex.org/programs/ci/ or contactDaphne Earley or Denise Cormaney at (202)628-8188.
***This report is provided courtesy of the Business Information Service for the NewlyIndependent States (BISNIS)***
#### § 1208.16 Appeals under another law, rule, or regulation.

Nothing in USERRA prevents an appellant who may appeal an agency action to the Board under any other law, rule, or regulation from raising a claim of a USERRA violation in that appeal. The Board will treat such a claim as an affirmative defense that the agency action was not in accordance with law (5 CFR 1201.56(b)(3)).
Exhibit 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE, ACCOUNTING AND

FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350

 

In connection with the Quarterly Report of New Pacific Ventures, Inc. (the "Company") on Form 10-QSB for the period ended April 30, 2006, asfiled with the Securities and Exchange Commission on the date hereof (the"Report"), I Gerry Jardine, President of the Company, hereby certifypursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of theSarbanes-Oxley Act of 2002, that:

   (1)  the Report fully complies withthe requirements of section 13(a) or 15(d) of the Securities Exchange Act of1934; and

   (2)  the information contained inthe Report fairly presents, in all material respects, the financial conditionand results of operations of the Company.

 

/s/Gerry JardineGerry JardinePresident/DirectorJune 13, 2006
#### JACKSON v. UNITED STATES.

No. 11828.

United States Court of Appeals, District of Columbia Circuit.

Argued March 19, 1954.

Decided April 8, 1954.

Writ of Certiorari Denied June 7, 1954.

See 74 S.Ct. 879.

Mr. T. Emmett McKenzie, Washington, D. C., for appellant.

Mr. John D. Lane, Asst. U. S. Atty., with whom Messrs. Leo A. Rover, U. S. Atty., and Lewis A. Carroll and Arthur J. McLaughlin, Asst. U. S. Attys., were on the brief, for appellee.

Before WILBUR K. MILLER, BAZE-LON and FAHY, Circuit Judges.

PER CURIAM.

Appellant was convicted on eight counts of an indictment charging illegal *241sale, purchase, and concealment of narcotic drugs. Consecutive sentences were imposed on two of the counts, numbered 11 and 14, which charged the sale of narcotic drugs without written order of the purchaser, in violation of the Harrison Narcotics Act.1 Sentences to run concurrently, some with that imposed on count 11, others with that on count 14, were imposed on the remaining six counts which charged the sale of narcotics not in or from the original stamped package, in violation of the Harrison Narcotics Act,2 and facilitating the concealment and sale of narcotics known to have been illegally imported, in violation of the Narcotic Drugs Import and Export Act.3

Appellant’s main contention is that in instructing the jury that, under the applicable statutes, the unexplained possession of narcotic drugs4 is sufficient evidence to authorize conviction, the trial court erred in instructing that actual, physical possession is not essential and that constructive possession is sufficient.

These instructions, however, were given only in connection with the charges of selling not in or from the original stamped package and facilitating concealment and sale. They were not given in connection with the charges in counts 11 and 14 of selling narcotics without a written purchase order. We find no error in the presentation of the case to the jury on these two counts, and in view of the concurrence of the sentences, it is unnecessary for us to resolve the questions presented as to the validity of the convictions on the remaining six counts. Kiyoshi Hirabayashi v. United States, 320 U.S. 81, 85, 63 S.Ct. 1375, 87 L.Ed. 1774.

Affirmed.

1

. 38 Stat. 786, as amended, 26 U.S.C. § 2554(a). Later amended, 67 Stat. 506, 26 U.S.C.A. § 2554(a) (Supp.1953).

2

. 38 Stat. 785, as amended, 26 U.S.C. § 2553(a). Later amended, 67 Stat. 506, 26 U.S.C.A. § 2553(a) (Supp.1953).

3

. 35 Stat. 614, as amended, 21 U.S.C. § 174 (Supp.1952).

4

. Or, in connection with the charges of selling not in or from the original stamped package, the possession of narcotics absent the appropriate tax-paid stamps.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; NIDDK KUH Fellowship Review.                    

*Date:*                         February 8, 2019.                    

*Time:*                         8:00 a.m. to 4:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814.                    

*Contact Person:*                         Xiaodu Guo, MD, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7023, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-4719,                         *guox@extra.niddk.nih.gov.*

This meeting notice is being published less than 15 days in advance of the meeting due to the partial Government shutdown of December 2018.

Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS)

Dated: January 25, 2019.

Melanie J. Pantoja,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2019-00352 Filed 1-30-19; 8:45 am]

 BILLING CODE 4140-01-P
### §6308. Biennial report to Congress

(a) Report Required.—The Secretary shall, not later than December 1 of every even-numbered year (beginning in 2008), submit to Congress a report on the outreach activities carried out by the Department.

(b) Content.—Each report under this section shall include the following:

(1) A description of the implementation during the preceding fiscal year of the current biennial plan under section 6302 of this title.

(2) Recommendations for the improvement or more effective administration of the outreach activities of the Department.

(Added Pub. L. 109–233, title IV, §402(a), June 15, 2006, 120 Stat. 410.)

#### **Editorial Notes**

#### Prior Provisions

Provisions similar to those in this section were contained in section 7726 of this title prior to repeal by Pub. L. 109–233.
Moldova: A Promising American Partner in Southeast Europe

----
Editorial Note on Part 20
Editorial Note: Nomenclature changes to part 20 appear at 68 FR 51355, Aug. 26, 2003.

§ 20.4 Rules against age discrimination. The rules stated in this section are limited by the exceptions contained in § 20.5. ( a ) General rule: No person in the United States shall, on the basis of age, be excluded from participation in, be denied the benefits of, or be subjected to discrimination under any program or activity receiving Federal financial assistance.
( b ) Specific rules: A recipient may not, in any program or activity receiving Federal financial assistance, directly or through contractual licensing, or other arrangements, use age distinctions or take any other actions which have the effect, on the basis of age, of: ( 1 ) Excluding individuals from, denying them the benefits of, or subjecting them to discrimination under, a program or activity receiving Federal financial assistance, or
( 2 ) Denying or limiting individuals in their opportunity to participate in any program or activity receiving Federal financial assistance.
( c ) The specific forms of age discrimination listed in paragraph (b) of this section do not necessarily constitute a complete list.
( d ) If a recipient operating a program or activity provides special benefits to the elderly or to children, such use of age distinctions shall be presumed to be necessary to the normal operation of the program or activity, notwithstanding the provisions of § 20.5.
EXHIBIT 31.1



CERTIFICATION



I, John H. Curtis, certify that:



1. I have reviewed this Annual Report on Form 10-K of Network Engines, Inc.;



2. Based on my knowledge, this report does not contain any
untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;



3. Based on my knowledge, the financial
statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;



4. The registrants other certifying
officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:



a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is
being prepared;



b) [Paragraph omitted in
accordance with SEC transition instructions contained in SEC Release 34-47986]



c) Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and



d) Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the
registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over
financial reporting; and



5. The
registrants other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors
(or persons performing the equivalent functions):



a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and
report financial information; and



b) Any
fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.



|Date: December 23, 2003 |  |  |  |  |  | /s/    JOHN H.
CURTIS
|----------------------- |  |  |  |  |  | ---------------------
|                        |  |  |  |  |  |